Abstract
Introduction
Cryptococcal meningitis is an infectious complication of immunecompromised states that carries a high rate of mortality orrelapse. Although Infectious Disease Society of America (IDSA)guidelines outline the recommended treatment regimen forcryptococcal meningitis, clinicians take a heterogenous clinicalapproach. This study examines the use of antifungal regimens intreating cryptococcal meningitis at a tertiary care hospital.
Recommended Citation
Grant, MD, Matthew
(2008)
"TJUH Adherence to IDSA Guidelines for the Treatment of Cryptococcal Meningitis,"
The Medicine Forum: Vol. 10, Article 6.
DOI: https://doi.org/10.29046/TMF.010.1.005
Available at:
https://jdc.jefferson.edu/tmf/vol10/iss1/6
